Back
VanEck Gold Miners ETF Vs. PTC Therapeutics Industry Stock Comparison
Buy
62
GDX
VanEck Gold Miners ETF
Last Price:
40.37
Seasonality Move:
-1.95%
Sell
40
PTCT
PTC Therapeutics
Last Price:
37.52
Seasonality Move:
3.92%
Buy
62
VanEck Gold Miners ETF (GDX)
is a Buy
Is VanEck Gold Miners ETF a Buy, Sell or Hold?
- The current VanEck Gold Miners ETF [GDX] share price is $40.36. The Score for GDX is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
- GDX is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
40
PTC Therapeutics (PTCT)
is a Sell
Is PTC Therapeutics a Buy, Sell or Hold?
- The current PTC Therapeutics [PTCT] share price is $37.56. The Score for PTCT is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- PTCT is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
GDX Stock Price Chart
What is VanEck Gold Miners ETF's stock price today?
-
The VanEck Gold Miners ETF share price today is $40.36
The current trend is moderately bullish and GDX is experiencing selling pressure, which indicates risk of future bearish movement.
PTCT Stock Price Chart
What is PTC Therapeutics's stock price today?
-
The PTC Therapeutics share price today is $37.56
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and PTCT is experiencing slight selling pressure.
GDX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.89 | Buy |
Relative Strength Index (14 RSI): | 57.13 | Buy |
Chaikin Money Flow: | -23329424 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (37.54 - 40.52) | Buy |
Bollinger Bands (100): | (34.6 - 38.82) | Buy |
PTCT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.06 | Buy |
Relative Strength Index (14 RSI): | 69.28 | Buy |
Chaikin Money Flow: | -221691 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (32.67 - 36.49) | Buy |
Bollinger Bands (100): | (31.89 - 36.41) | Buy |
GDX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 40.54 | Sell |
20-day SMA: | 39.04 | Buy |
50-day SMA: | 38.1 | Buy |
200-day SMA: | 33.4 | Buy |
8-day EMA: | 40.54 | Sell |
20-day EMA: | 39.6 | Buy |
50-day EMA: | 38.3 | Buy |
200-day EMA: | 34.61 | Buy |
PTCT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 36.67 | Buy |
20-day SMA: | 34.47 | Buy |
50-day SMA: | 33.72 | Buy |
200-day SMA: | 31.08 | Buy |
8-day EMA: | 36.52 | Buy |
20-day EMA: | 35.25 | Buy |
50-day EMA: | 34.22 | Buy |
200-day EMA: | 32.66 | Buy |
VanEck Gold Miners ETF Earnings Growth & GDX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
PTC Therapeutics Earnings Growth & PTCT Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.13 per share, an increase next quarter of $0.67 per share, an increase this year of $0.38 per share, and an increase next year of $0.67 per share.
VanEck Gold Miners ETF Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
PTC Therapeutics Technical Analysis
Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
---|---|---|---|---|---|---|---|---|---|---|
Sep | ||||||||||
16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |